Genetic and environmental interaction in Japanese type 2 diabetics

被引:20
作者
Matsuoka, K [1 ]
机构
[1] Keio Univ, Sch Med, Dept Internal Med, Saiseikai Diabet Ctr,Minato Ku, Tokyo 1080073, Japan
关键词
type; 2; diabetes; life-style related disease; insulinogenic index; body weight; aldehyde dehydrogenese 2;
D O I
10.1016/S0168-8227(00)00174-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In Japanese type 2 diabetes, which occupies more than 95%, it is an increasingly important problem as a life-style related disease. The total diabetic population is estimated as similar to7 million with a prevalence of similar to 6%. Along with genetically low postprandial insulin secretion, they are found to be less tolerable to being overweight to develop insulin resistance. The body weight change in the prediabetic era consisting of 508 male patients treated on their diet alone was reviewed and it was found that a few kilograms of weight gain could be a cause of insulin resistance. Moreover, inactive aldehyde dehydrogenese 2 (ALDH2), which is common in Japanese, is found to be a factor in the development of hyperglycemia. In 163 diabetics, HbAlc of the inactive ALDH2 group was 8.1 +/- 1.3, while that of active ALDH2 was 7.5 +/- 0.9% (P < 0.05) in a light, social drinking group. However, Japanese type 2 diabetes is also changing. In recent years, the data from a 75-g oral glucose tolerance test of 2121 clients showed that insulinogenic index of clients with impaired glucose tolerance was similar to that of a normal glucose tolerance group and that the area under the insulin curve (AUC) was high in younger diabetics. From a life-style modification perspective, the importance of body weight control by diet and exercise as well as refraining from excessive drinking should be emphasized. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:S17 / S22
页数:6
相关论文
共 15 条
[1]   PREVALENCE AND INCIDENCE OF DIABETES-MELLITUS BY WHO CRITERIA [J].
AKAZAWA, Y .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1994, 24 :S23-S27
[2]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[3]  
2-S
[4]  
[Anonymous], 1999, J JPN DIABETES SOC
[5]  
*COMM JAP DIAB SOC, 1979, J JPN DIABETES SOC, V25, P859
[6]  
*COMM JAP DIAB SOC, 1970, J JAPAN DIAB SOC, V13, P1
[7]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[8]  
*HLTH WELF STAT AS, 1999, J HLTH WELFARE STAT, P98
[9]  
ITO C, 1998, J JPN DIABETES SOC, V41, pA33
[10]  
*JSSO, 1999, J JPN SOC STUDY OBES, V5, P72